The abstract is read at the publisher; the summary is JClub's.
In individuals with type 1 diabetes, older epigenetic age acceleration for phenotypic age and shorter epigenetically predicted telomere lengths are significantly associated with diabetic kidney disease.
- Why it matters: It is unclear whether epigenetic age acceleration tracks DKD risk and whether it reflects worsening kidney function in type 1 diabetes.
- What they did: The study tested associations using 10 epigenetic clocks across two cohorts, then examined whether epigenetic age measures predicted progression from normolbuminuria to severely increased albuminuria and to end-stage kidney disease.
- The result: Increased EAA accompanied progression to severely increased albuminuria, and age, epigenetic age, and EAA significantly predicted progression to end-stage kidney disease, supporting epigenetic biomarkers for DKD onset and progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.